Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Intercure Ltd. - ordinary shares (OQ:INCR)

Business Focus: N/A

Mar 28, 2024 09:31 am ET
Thinking about buying stock in Braze, Velo3D, InterCure, Equillium, or Bioatla?
NEW YORK, March 28, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BRZE, VLD, INCR, EQ, and BCAB.
Mar 22, 2024 11:58 am ET
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company outside of North America, is thrilled to congratulate The Federal Republic of Germany for the passing of the “CannG” Cannabis Act, which is expected to take effect on April 1, 2024. On the backdrop of this monument
Feb 13, 2024 04:46 pm ET
InterCure Provides an Update Regarding Nir Oz Facility
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel and outside of North America, reports today that, further to the Company’s press release issued on October 17,...
Jan 31, 2024 09:27 am ET
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel and outside of North America, announced today that it has entered into a share purchase agreement (the...
Nov 20, 2023 08:31 am ET
Thinking about buying stock in LogicMark, Realty Income Corp, YPF SA, GD Culture Group, or InterCure?
NEW YORK, Nov. 20, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LGMK, O, YPF, GDC, and INCR.
Oct 31, 2023 04:39 pm ET
InterCure Wins Cannolam Arbitration Proceeding
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel and outside of North America, reports today that, further to the Company’s press release issued on August 31,...
Oct 17, 2023 05:04 pm ET
InterCure Provides an Update Regarding the Security Situation in Israel
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel and outside of North America, today addressed the status of the security situation in the State of Israel, and...
Aug 31, 2023 07:45 pm ET
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) is pleased to announce its financial and operating results for the six months ended June 30, 2023. All amounts are expressed in New Israeli Shekels (NIS) or...
Jul 10, 2023 05:00 pm ET
InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the "Company"), announced today that its board of directors (“Board”) has approved the voluntarily delisting of the Company’s common shares (“Shares”) from the...
Jun 09, 2023 05:18 pm ET
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the "Company"), reports today that, further to the Company’s press release issued on February 1, 2023, where the Company had reported the termination of the...
May 15, 2023 05:59 pm ET
InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure") today announced that Alexander Rabinovitch, CEO of InterCure, will participate in the Cowen 3rd Annual European Cannabis Conference, taking place May 16th, 2023 in...
May 15, 2023 05:45 pm ET
InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“InterCure” or the “Company”) is pleased to announce its financial and operating results for the first quarter ended March 31, 2023. All amounts are expressed in New...
May 15, 2023 08:30 am ET
InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business
(NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure'' or the "Company"), the largest and fastest growing medical cannabis company outside of North America, is pleased to announce that its Chairman and former Prime Minister of Israel Mr. Ehud...
Apr 25, 2023 07:19 pm ET
InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company outside of North America announces that on April 24, 2023, it was informed that a lawsuit was filed against...
Apr 24, 2023 05:59 pm ET
InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading cannabis company outside of North America, announces that on April 23, 2023, it was informed that an application for approval of a...
Apr 20, 2023 08:30 am ET
InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading cannabis company outside of North America, and TYSON 2.0, a premier cannabis brand known for high-quality cannabis products,...
Apr 03, 2023 03:27 pm ET
InterCure Reschedules 2022 Full Year Results Conference Call
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) announced today that it has rescheduled its previously announced conference call to discuss the company's financial results for the full year ended...
Mar 31, 2023 08:00 pm ET
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) is pleased to announce its financial and operating results for the fourth quarter and year ended December 31, 2022. All amounts are expressed in...
Feb 14, 2023 08:30 am ET
InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“InterCure” or the “Company”) the biggest and most profitable cannabis company outside of north America, announced today that it has filed a lawsuit against Cann Pharmaceuticals...
Feb 01, 2023 08:30 am ET
InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company") announces that, further to the merger agreement with Cann Pharmaceutical Ltd. (“Better”) dated as of February 13, 2022, pursuant to which and...
Dec 19, 2022 08:30 am ET
InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the largest and fastest growing medical cannabis company outside of North America, today announced that it has entered into a definitive...
Dec 08, 2022 09:30 am ET
InterCure to Participate in Cowen 5th Annual Cannabis Conference
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in Cowen 5th Annual Cannabis Conference, taking place December 8th,...
Dec 05, 2022 04:30 pm ET
InterCure Announces the Withdrawal of a Class Action Lawsuit against it
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company") is pleased to announce the withdrawal of a class action lawsuit against it (the “Regenera Lawsuit”). The Regenera Lawsuit was described in the...
Nov 23, 2022 04:30 pm ET
Update regarding Better Transaction
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the "Company") is hereby providing an update that further to the announcement from February 16, 2022, regarding the signed agreement with Cann Pharmaceutical Ltd....
Nov 17, 2022 08:17 am ET
Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ( “Organigram”), a leading Canadian licensed producer of cannabis, and Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) Israel’s...
Nov 17, 2022 08:00 am ET
Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ( “Organigram”) a leading Canadian licensed producer of cannabis and Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) Israel’s largest and most established pharmaceutical cannabis producer, today jointly announced that they have entered into a new multi-year agreement (the “New Strategic Agreement”) for Organigram to continue supply of dried flower to InterCure.
Nov 15, 2022 11:18 am ET
CORRECTION and MULTIMEDIA UPDATE -- InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth
In a release issued under the same headline earlier today, by InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), please note that multiple numbers were incorrect and have been updated. The corrected release follows: Eleventh consecutive...
Nov 15, 2022 09:03 am ET
InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) is pleased to announce its financial and operating results for the third quarter ended September 30, 2022. All amounts are expressed in New...
Nov 11, 2022 08:32 am ET
InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million – 63% Growth YoY
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the “Company”) today announced record preliminary financial results for the Third quarter of 2022. All amounts are expressed in Canadian dollars ($) or New Israeli Shekels...
Sep 16, 2022 04:30 pm ET
Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders
Intercure Ltd. (the “Company”) announces today the results of the Annual and Special General Meeting of shareholders of the Company, held on Thursday, September 15, 2022, in Bnei Brak, Israel (the “Meeting”). At the Meeting, all of the proposals...
Aug 15, 2022 09:15 am ET
InterCure Reports Record Breaking Second Quarter Financial Results
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the “Company”) is pleased to announce its financial results for the second quarter of 2022 and is pleased to provide shareholders with a business update. All amounts are...
Aug 11, 2022 10:30 am ET
InterCure to Release its Q2 2022 Results and Hold a Conference Call
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it plans to release financial results for the second quarter of 2022 after market close on Monday, August 15, 2022. InterCure...
Jul 21, 2022 09:00 am ET
InterCure Reports Record Preliminary 2022 Second Quarter Revenue – More Than Double YoY and 9% QoQ Growth
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the “Company”) today announced record preliminary financial results for the second quarter of 2022. All amounts are expressed in Canadian dollars ($) or New Israeli Shekels...
Jul 18, 2022 08:00 am ET
Clever Leaves Announces First Export to Israeli Partner InterCure
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the first commercial export to Israel of high THC...
Jun 21, 2022 08:40 am ET
InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the “Company”) announced today the successful opening of the first flagship Cookies store in Austria, located in the Neubau district of Vienna.  The flagship location offers...
Jun 02, 2022 08:30 am ET
InterCure and Cookies Successfully Launch Flagship Pharmacy in Be'er Sheva, Israel
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the “Company”) announced today the grand opening of its flagship Cookies pharmacy in Be'er Sheva, the largest city in Israel's southern region, known as the capital of the...
May 16, 2022 05:50 pm ET
InterCure Begins 2022 with Record Breaking First Quarter Financial Results
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) is pleased to announced its financial results for the first quarter of 2022 and is pleased to provide shareholders with a business update. All...
May 16, 2022 01:30 am ET
InterCure to Release its Q1 2022 Results and Hold a Conference Call
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it plans to release financial results for the first quarter of 2022 after market close on Monday, May 16, 2022. The Company...
May 09, 2022 11:20 am ET
InterCure to Participate in Upcoming Investor Conferences in May 2022
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that that Alex Rabinovitch, Chief Executive Officer and Amos Cohen, Chief Financial Officer, will participate in the following...
May 03, 2022 11:28 am ET
InterCure to Participate in A.G.P.’s Spring Consumer Cannabis Conference
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in Alliance Global Partners Spring Consumer Cannabis Conference,...
Apr 06, 2022 12:39 am ET
InterCure Reports Record Breaking Q4 and 2021 Results – Exceeded Preliminary Results
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) is pleased to announce its financial and operating results for the fourth quarter and year ended December 31, 2021. References herein to...
Apr 05, 2022 08:47 am ET
InterCure Expects to Publish its full Audited Fourth Quarter and Full Year 2021 Results Prior to the TSX Closing on April 5, 2022
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) announced a delay in the publication of the Company's audited financial statements and accompanying notes due to immaterial technical matters being...
Apr 04, 2022 09:33 am ET
CORRECTING and REPLACING -- InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1)
In a release published under the same headline earlier today by InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), please note that the monetary units in the tables should be Canadian dollars, not New Israeli Shekels as previously stated....
Apr 04, 2022 08:29 am ET
InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1)
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) is pleased to announce its estimated financial and operating results for the fourth quarter and year ended December 31, 2021. All amounts are...
Apr 03, 2022 03:35 am ET
InterCure to Announce Q4 & Year-End 2021 Financial Results on April 4, 2022
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that the Company will release financial results for its fourth quarter fiscal 2021 ended December 31, 2021 before financial markets...
Mar 30, 2022 09:00 am ET
InterCure to Hold 2021 Q4 & Year-End Webcast
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that it plans to release financial results for the fourth quarter of 2021 after market close on Thursday, March 31, 2022. The...
Mar 22, 2022 08:30 am ET
InterCure and Clever Leaves Announce International Strategic Partnership
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) and Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves”), a leading multinational operator and licensed producer of...
Mar 15, 2022 11:34 am ET
InterCure to Participate in ROTH Capital’s 34th Annual Conference
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in ROTH Capital’s 34th Annual Conference, taking place March 15,...
Mar 01, 2022 01:00 am ET
InterCure Announces Partnership with Altman Health
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced it has signed a definitive agreement (the "Agreement") with Altman Health LP (“Altman Health”), the market leader with an...
Feb 16, 2022 01:00 am ET
InterCure Signs Definitive Agreement to Acquire Multi-National Medical Cannabis Producer “Better”
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced it has signed a definitive agreement (the "Agreement") with Cann Pharmaceutical Ltd. (“Better”), a pioneering Israeli medical...
Feb 08, 2022 01:00 am ET
InterCure Reports Record Preliminary 2021 Fourth Quarter Revenue - 3 Times YoY and 24% QoQ Growth
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced record preliminary financial results for the fourth quarter of 2021. All amounts are expressed in Canadian dollars ($) or New...
Dec 02, 2021 08:15 am ET
InterCure Announces European Expansion with International Cannabis Brand Cookies
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced its international expansion into Europe through a partnership with iconic cannabis brand Cookies. The parties entered into a...
Nov 29, 2021 08:30 am ET
InterCure to Participate in Cowen’s 4th Annual Cannabis Conference
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in Cowen’s 4th Annual Cannabis Conference, taking place virtually...
Nov 15, 2021 07:00 pm ET
InterCure Announces Record Third Quarter Financial Results with 3 Times YoY Revenue Growth and 36% QoQ Growth
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced financial results for the third quarter of 2021 and is pleased to provide shareholders with a business update. All amounts are...
Nov 15, 2021 06:50 pm ET
InterCure Expands Pharmacy Chain in Israel; Surpasses One-Ton Medical Cannabis Products Dispensed Per Month
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced the addition of four pharmacies to its leading pharmacy chain GIVOL, focused on dispensing pharmaceutical grade medical cannabis,...
Nov 11, 2021 08:00 am ET
InterCure Schedules Third Quarter 2021 Financial Results Conference Call
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it plans to release financial results for the third quarter of 2021 before market open on Tuesday, November 16, 2021. The...
Oct 25, 2021 01:30 am ET
InterCure Announces Record Preliminary Third Quarter Revenue of CAD$24 million - 3 Times YOY and 36% QOQ Growth
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced preliminary unaudited revenue of CAD$24 million (NIS 61 million) for the third quarter of 2021, representing another record quarter...
Oct 13, 2021 12:15 pm ET
InterCure to Present in Benzinga Cannabis Capital Conference
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will present at the Benzinga Cannabis Capital Conference on Thursday, October 14,...
Oct 12, 2021 02:00 am ET
InterCure CEO Alex Rabinovitch Purchases Over 420,000 Shares of Company Stock in The Open Market
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that CEO Alexander Rabinovitch purchased, throughout the month of September 2021, a total of 423,501 shares of the Company’s...
Sep 13, 2021 08:43 am ET
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations
Sep 13, 2021 07:32 am ET
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
NEW YORK, Sept. 13, 2021 /PRNewswire/ -- Virtual Investor Conferences® and KCSA Strategic Communications today announced that the presentations from the September 8th & 9th Cannabis Industry Virtual lnvestor Conference are now available for on-demand viewing at VirtualInvestorConferences.com.
Sep 08, 2021 09:57 am ET
InterCure to Webcast Live at VirtualInvestorConferences.com September 9th
NEW YORK and TORONTO and HERZLIYA, Israel, Sept. 8, 2021 /PRNewswire/ -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the "Company") today announced that Alexander Rabinovitch, CEO of InterCure, will present live at VirtualInvestorConferences.com on September 9th.
Sep 03, 2021 09:29 am ET
InterCure Re-Announces its Record-Breaking Second Quarter Financial Results With 4 Times YOY Revenue Growth - Following NASDAQ Listing
InterCure Ltd. (NASDAQ: INCR, TSX: INCR.U, TASE: INCR) (dba Canndoc) (the “Company”) is pleased to announce its financial results for the second quarter of 2021 and provide a business update. All amounts are expressed in New Israeli Shekels (NIS)...
Sep 03, 2021 08:35 am ET
Cannabis Executives Present: Cannabis Investor Conference September 8th & 9th
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com
Sep 02, 2021 09:39 am ET
InterCure Continuing its Medical Cannabis Consolidation Strategy, Announces Strategic Acquisition of Cannomed Pharmacy Chain
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it has signed an agreement in which InterCure will purchase strategic assets from Cannomed (TASE: CNMD), an Israel-based...
Sep 01, 2021 01:00 am ET
InterCure Commences Trading on NASDAQ Under the Symbol “INCR”
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (the “Company”) is pleased to announce the Company’s common shares will commence trading today on The NASDAQ Global Market (the “Nasdaq”) under the ticker symbol “INCR”. The...
Jan 29, 2018 06:57 pm ET
INCR Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Syneos Health, Inc. (formerly INC Research Holdings, Inc.)  Investors
BENSALEM, Pa., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors of the January 30, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased...
Jan 25, 2018 05:30 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Syneos Health (SYNH) (Formerly INC Research Holdings, Inc.) and Encourages Investors to Contact the Fir
Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired shares of Syneos Health (NASDAQ:SYNH) (formerly INC Research Holdings, Inc. (NASDAQ:INCR)) between May 10, 2017 and November 9, 2017 (the “Class Period”). Investors have until January 30, 2018 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Jan 25, 2018 05:12 pm ET
Holzer & Holzer Files Class Action Suit Against INC Research Holdings
Holzer & Holzer, LLC announces that it has filed a class action lawsuit on behalf of investors in INC Research Holdings, Inc. (“INC” or the “Company”) (NASDAQ: INCR), now doing business as Syneos Health, Inc., who purchased INC shares between May 10, 2017 and November 8, 2017. The case is pending in the United States District Court for the Eastern District of North Carolina and captioned Vaitkuvienė v. Syneos Health, Inc., et al., Case No. 18-cv-0029-H.
Jan 24, 2018 01:30 pm ET
Scott+Scott, Attorneys at Law, LLP Reminds Investors of January 30 Deadline in Securities Class Action Against INC Research Holdings, Inc. (INCR)
Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, reminds investors that class action lawsuits have been filed against INC Research Holdings, Inc. (NASDAQ: INCR) (“INC” or the “Company”) and certain of its officers, re
Jan 23, 2018 02:56 pm ET
Glancy Prongay & Murray Reminds Investors of the January 30, 2018 Deadline in the Class Action Lawsuit Against Syneos Health, Inc. (formerly INC Research Holdings, Inc.) Investors
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the January 30, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Syneos Health, Inc. (“Syneos” or the “Company”) (NASDAQ:
Jan 22, 2018 02:12 pm ET
Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against INC Research Holdings, Inc.; January 30 Deadline Approaching - INCR
NEW YORK, Jan. 22, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of INC Research Holdings, Inc. (NASDAQ: INCR) from May 10, 2017 through November 9, 2017, inclusive (the "Class Period"). The lawsuit seeks to recover damages for INC Research investors under the federal securities laws.
Jan 22, 2018 09:00 am ET
INCR Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Syneos Health, Inc. (formerly INC Research Holdings, Inc.) Investors
Law Offices of Howard G. Smith reminds investors of the January 30, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Syneos Health, Inc. (“Syneos” or the “Company”) (NASDAQ: 
Jan 20, 2018 05:30 am ET
FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In INC Research H
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of INC Research Holdings, Inc. (Nasdaq: INCR) (“INC” or the “Company”) securities during the period between May 10, 2017 and November 9, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until January 30, 2018 to seek appointment as lead plaintiff.
Jan 18, 2018 10:10 am ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against INC Research Holdings, Inc. (INCR) & Lead Plaintiff Deadline - February 2, 2018
NEW YORK, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against INC Research Holdings, Inc. ("INC Research" or the "Company") (NASDAQ:INCR) and...
Jan 17, 2018 06:23 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In INC Research Holdings, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in INC Research Holdings, Inc. (“INC” or the “Company”) (NASDAQ:INCR) of the January 30, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Jan 17, 2018 05:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against INC Research Holdings, Inc. (INCR) and Encourages Investors to Contact the Firm Before January 30th
Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired INC Research Holdings, Inc. (NASDAQ:INCR) securities between May 10, 2017 and November 9, 2017 (the “Class Period”). Investors have until January 30, 2018 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Jan 15, 2018 02:00 pm ET
The Klein Law Firm Notifies Shareholders of a Class Action Filed on Behalf of Syneos Health, Inc. (formerly INC Research Holdings, Inc.) Shareholders and a Lead Plaintiff Deadline of January 30, 2018
NEW YORK, Jan. 15, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Syneos Health, Inc. (NASDAQ:SYNH) (formerly known as INC Research Holdings, Inc. and...
Jan 11, 2018 08:00 am ET
Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for INC Research Holdings, Inc. Shareholders – INCR
RADNOR, Pa., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP reminds shareholders of INC Research Holdings, Inc. (NASDAQ:INCR) (“INCR” or the “Company”), now known as Syneos Health, Inc. (NASDAQ:SYNH), that a class action lawsuit...
Jan 10, 2018 04:01 pm ET
INCR INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Syneos Health, Inc. (formerly INC Research Holdings, Inc.) and a Lead Plaintiff Deadline of January 3
NEW YORK, Jan. 10, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf...
Jan 10, 2018 11:09 am ET
Scott+Scott, Attorneys at Law, LLP Reminds Investors of January 30 Deadline in Securities Class Action Against INC Research Holdings, Inc. (INCR)
Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, reminds investors that class action lawsuits have been filed against INC Research Holdings, Inc. (NASDAQ: INCR) (“INC” or the “Company”) and certain of its officers, re
Jan 10, 2018 09:00 am ET
Syneos Health Releases 2018 Commercial Trends Forecast
The Commercial Forecast Joins a Series of Consumer, Digital, Communications and Healthcare Trends Reports that Reveals Shifts in Media and Medicine Impacting Stakeholder Engagement
Jan 08, 2018 05:00 pm ET
Jan 08, 2018 10:09 am ET
INCR LOSS NOTICE: Rosen Law Firm Reminds INC Research Holdings, Inc. Investors of Important Deadline in Class Action – INCR
NEW YORK, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of INC Research Holdings, Inc. (NASDAQ:INCR) from May 10, 2017 through November 9, 2017, inclusive (the...
Jan 04, 2018 10:30 am ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against INC Research Holdings, Inc. (INCR) & Lead Plaintiff Deadline - February 2, 2018
NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against INC Research Holdings, Inc. ("INC Research" or the "Company") (NASDAQ:INCR) and...
Jan 04, 2018 09:28 am ET
INC Research/inVentiv Health Becomes Syneos Health™
New Identity Signifies Industry’s Only Fully Integrated, End-to-End Biopharmaceutical Solutions Organization
Jan 03, 2018 05:36 pm ET
INC Research/inVentiv Health Announces CFO Transition
Greg Rush to Step Down as Chief Financial Officer to Pursue Another Opportunity
Jan 03, 2018 02:18 pm ET
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In INC Research Holdings, Inc. (Nasdaq: INCR) To Contact Brower Piven Before The Lead Plainti
STEVENSON, Md., Jan. 03, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District...
Dec 28, 2017 11:11 am ET
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in INC Research Holdings, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of INC Research Holdings, Inc. (Nasdaq: INCR) (“INC” or the “Company”) securities during the period between May 10, 2017 and November 9, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until January 30, 2018 to seek appointment as lead plaintiff.
Dec 28, 2017 08:00 am ET
SHAREHOLDER REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Class Action Lawsuit Filed against INC Research Holdings, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP reminds INC Research Holdings, Inc. (NASDAQ: INCR) (“INCR” or the “Company”) shareholders that a class action lawsuit has been filed on behalf of purchasers of the Company’s securities between May 10, 2017 and November 9, 2017, inclusive (the “Class Period”).
Dec 27, 2017 12:56 pm ET
The Klein Law Firm Reminds Shareholders of a Class Action Filed on Behalf of INC Research Holdings, Inc. Shareholders and a Lead Plaintiff Deadline of January 30, 2018
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of INC Research Holdings, Inc. (NASDAQ:INCR) who purchased shares between May 10, 2017 and November 9, 2017. The action, which was filed in the United States District Court for the Southern District of New York, alleges that the Company violated federal securities laws.
Dec 22, 2017 03:20 pm ET
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against INC Research Holdings, Inc. – INCR
NEW YORK, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of INC Research Holdings, Inc. (NASDAQ:INCR)...
Dec 21, 2017 01:15 pm ET
INCR EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving INC Research Holdings, Inc. and a Lead Plaintiff Deadline of January 30, 2018
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased INC Research Holdings, Inc. ("INCR") (NASDAQ: INCR) securities between May 10, 2017 and November 9, 2017.
Dec 19, 2017 03:00 am ET
The Klein Law Firm Announces the Commencement of a Class Action Filed on Behalf of INC Research Holdings, Inc. Shareholders and a Lead Plaintiff Deadline of January 30, 2018
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of INC Research Holdings, Inc. (NASDAQ:INCR) who purchased shares between May 10, 2017 and November 9, 2017. The action, which was filed in the United States District Court for the Southern District of New York, alleges that the Company violated federal securities laws.
Dec 18, 2017 02:52 pm ET
The Klein Law Firm Announces a Class Action Filed on Behalf of INC Research Holdings, Inc. Shareholders and a Lead Plaintiff Deadline of January 30, 2018
NEW YORK, Dec. 18, 2017 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of INC Research Holdings, Inc. (NASDAQ:INCR) who purchased shares between May 10, 2017...
Dec 18, 2017 02:26 pm ET
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In INC Research Holdings, Inc. (Nasdaq: INCR) To C
STEVENSON, Md., Dec. 18, 2017 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District...
Dec 15, 2017 07:31 pm ET
Robbins Arroyo LLP: INC Research Holdings, Inc. (INCR) Misled Shareholders According to a Recently Filed Class Action
Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against INC Research Holdings, Inc. (NasdaqGS: INCR) on behalf of all purchasers of INC securities between May 10, 2017 and November 9, 2017, for alleged violations of the Securities Exchange Act of 1934 by INC's o
Dec 15, 2017 02:25 pm ET
INCR INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving INC Research Holdings, Inc. and a Lead Plaintiff Deadline of January 30, 2018
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased INC Research Holdings, Inc. ("INCR") (NASDAQ:INCR) securities between May 10, 2017 and November 9, 2017.
Dec 15, 2017 08:00 am ET
Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for INC Research Holdings, Inc. Shareholders
RADNOR, Pa., Dec. 15, 2017 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds INC Research Holdings, Inc. (NASDAQ:INCR) (“INCR” or the “Company”) shareholders that a class action lawsuit has been filed against...
Dec 14, 2017 06:09 pm ET
INC Research/inVentiv Health to Present at Upcoming J.P. Morgan Healthcare Conference
RALEIGH, N.C., Dec. 14, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the 36th Annual J.P. Morgan Healthcare...
Dec 14, 2017 03:00 am ET
INCR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving INC Research Holdings, Inc. and a Lead Plaintiff Deadline of January 30, 2018
NEW YORK, Dec. 14, 2017 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf...
Dec 13, 2017 04:07 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In INC Research Holdings, Inc. To Contact The Firm
NEW YORK, Dec. 13, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in INC Research Holdings, Inc. ("INC" or the "Company") (NASDAQ: INCR) of the January 30, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Dec 12, 2017 04:58 pm ET
INCR LOSS NOTICE: Rosen Law Firm Reminds INC Research Holdings, Inc. Investors of Important Deadline in Class Action – INCR
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of INC Research Holdings, Inc. (NASDAQ: INCR) from May 10, 2017 through November 9, 2017, inclusive (the “Class Period”) of the important January 30, 2018 lead plaintiff deadline in the class action.. The lawsuit seeks to recover damages for INC Research investors under the federal securities laws.
Dec 12, 2017 03:00 pm ET
Dec 12, 2017 09:51 am ET
Kessler Topaz Meltzer & Check, LLP Announces Shareholder Lawsuit Filed against INC Research Holdings, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against INC Research Holdings, Inc. (NASDAQ: INCR) (“INCR” or the “Company”) on behalf of purchasers of the Company’s securities between May 10, 2017 and November 9, 2017, inclusive (the “Class Period”).
Dec 11, 2017 03:15 pm ET
The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by INC Research Holdings, Inc.
The Klein Law Firm announces the commencement of an investigation of INC Research Holdings, Inc. (NASDAQ:INCR) concerning possible violations of federal securities laws.
Dec 08, 2017 02:00 pm ET
The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by INC Research Holdings, Inc. (INCR)
The Klein Law Firm announces the commencement of an investigation of INC Research Holdings, Inc. (NASDAQ: INCR) concerning possible violations of federal securities laws.
Dec 07, 2017 07:12 am ET
INC Research/inVentiv Health Strengthens Leadership of Commercial Solutions
Michelle Keefe Appointed President, Commercial Solutions, Bringing More Than 25 Years of Experience in the Life Sciences Industry
Dec 06, 2017 02:00 am ET
INCR INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of INC Research Holdings, Inc.
The Law Offices of Vincent Wong notifies investors of an investigation concerning whether INC Research Holdings, Inc. (“INC” or the “Company”) (NASDAQ: INCR) violated federal securities laws.
Dec 05, 2017 01:46 pm ET
INCR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of INC Research Holdings, Inc.
The Law Offices of Vincent Wong notifies investors of an investigation concerning whether INC Research Holdings, Inc. (“INC” or the “Company”) (NASDAQ: INCR) violated federal securities laws.
Dec 04, 2017 03:26 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In INC Research Holdings, Inc. To Contact The Firm
NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in INC Research Holdings, Inc. (“INC” or the “Company”) (NASDAQ:INCR) of the January 30, 2018 deadline to seek...
Dec 04, 2017 02:28 pm ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of INC Research Holdings, Inc.-- INCR
Levi & Korsinsky announces it has commenced an investigation of INC Research Holdings, Inc. (NASDAQ:INCR) (“INC” or the “Company”) concerning possible violations of federal securities laws.
Dec 04, 2017 12:09 pm ET
INCR INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of INC Research Holdings, Inc. Investors and Encourages Investors to Contact the Firm
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased INC Research Holdings, Inc. (“INCR” or the “Company”) (NASDAQ: INCR) securities between May 10, 2017 and November 9, 2017, inclusive (the “Class Period”). INCR investors have until January 30,
Dec 04, 2017 10:50 am ET
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against INC Research Holdings, Inc. – INCR
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of INC Research Holdings, Inc. (NASDAQ:INCR) from May 10, 2017 through November 9, 2017, inclusive (the “Class Period”). The lawsuit seeks to recover damages for INC Research investors under the federal securities laws.
Dec 01, 2017 07:37 pm ET
Glancy Prongay & Murray LLP Files a Securities Class Action on Behalf of INC Research Holdings, Inc. Investors and Encourages Investors to Contact the Firm
Glancy Prongay & Murray LLP (“GPM”) announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York (Docket Number 1:17-cv-09457) on behalf of persons and entities that acquired INC Research Holdings, Inc. (“INCR” or the “Company”) (NASDAQ: 
Nov 29, 2017 07:40 am ET
Report: Exploring Fundamental Drivers Behind Microsoft, Equinix, Fitbit, INC Research, Progressive, and MannKind — New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Nov. 29, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Microsoft Corporation (NASDAQ:MSFT), Equinix, Inc. (NASDAQ:EQIX),...
Nov 28, 2017 07:09 am ET
Johnson Fistel, Announces Investigations of INC Research Holdings, Inc., Acorda Therapeutics, Inc., and Shopify Inc.; Investors Encouraged to Contact Firm
SAN DIEGO, Nov. 28, 2017 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against INC Research Holdings, Inc., Acorda Therapeutics, Inc., and Shopify Inc. as detailed below:
Nov 13, 2017 02:05 pm ET
INCR INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of INC Research Holdings, Inc. Investors
Law Offices of Howard G. Smith continues its investigation on behalf of INC Research Holdings, Inc. (“INC Research” or the “Company”) (NASDAQ: INCR) investors concerning the Company and its officers’ possible violations of federal securities laws.
Nov 12, 2017 03:08 pm ET
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of INC Research Holdings, Inc.
Levi & Korsinsky announces it has commenced an investigation of INC Research Holdings, Inc. (NASDAQ:INCR) (“INC” or the “Company”) concerning possible violations of federal securities laws.
Nov 10, 2017 05:03 pm ET
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against INC Research Holdings, Inc. – INCR
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of purchasers of the securities of INC Research Holdings, Inc. (NASDAQ:INCR) resulting from allegations that INC Research may have issued materially misleading business information to the investing public.
Nov 10, 2017 03:00 pm ET
Glancy Prongay & Murray LLP Continues Investigation on Behalf of INC Research Holdings, Inc. Investors (INCR)
Glancy Prongay & Murray LLP (“GPM”) continues its investigation on behalf of INC Research Holdings, Inc. (“INCR” or the “Company”) (NASDAQ:
Nov 10, 2017 12:41 pm ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of INC Research Holdings, Inc. (INCR)
NEW YORK, Nov. 10, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of INC Research Holdings, Inc. ("INC Research" or the "Company") (NASDAQ: INCR). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/incr.
Nov 10, 2017 11:36 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of INC Research Holdings, Inc. - INCR
NEW YORK, Nov. 10, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of INC Research Holdings, Inc. ("INC Research" or the "Company") (NASDAQ: INCR).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.
Nov 10, 2017 10:00 am ET
INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of INC Research Holdings, Inc. Investors (INCR)
Law Offices of Howard G. Smith announces an investigation on behalf of INC Research Holdings, Inc. (“INCR” or the “Company”) (NASDAQ: INCR) investors concerning the Company and its officers’ possible violations of federal securities law. To obtain information or aid in the investigation, please visit the INCR page on our website at ww
Nov 09, 2017 10:05 pm ET
Glancy Prongay & Murray LLP Commences Investigation on Behalf of INC Research Holdings, Inc. Investors (INCR)
Glancy Prongay & Murray LLP (“GPM”) commences its investigation on behalf of INC Research Holdings, Inc. (“INCR” or the “Company”) (NASDAQ: INCR) investors concerning the Company and its officers’ possible violations of federal securities law. To obtain information or aid in the investigation, please visit t
Nov 09, 2017 05:22 pm ET
INC Research (INCR) Alert: Johnson Fistel Investigates INC Research Holdings, Inc.; Investors Suffering Losses Encouraged to Contact Firm
SAN DIEGO, Nov. 9, 2017 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by INC Research Holdings, Inc. ("INC Research") (NASDAQ: INCR). INC Research is a contract research organization providing various clinical development services for the biopharmaceutical and medical device industries in North America, Europe, the Middle East and Africa, the Asia-Pacific, and Latin America.
Nov 09, 2017 03:12 pm ET
INVESTOR ALERT: Investigation of INC Research Holdings Announced by Holzer & Holzer
Holzer & Holzer, LLC is investigating whether INC Research Holdings, Inc. (“INC Research” or the “Company”) (NASDAQ: INCR) complied with the federal securities laws. On November 9, 2017, INC Research reported its first financial results after combining with inVentiv Health. The Company’s combined results were negatively impacted by merger-related expenses, an impairment charge and increased amortization expenses. The price of INC Research stock fell significantly following the announcement.
Nov 03, 2017 04:31 pm ET
INC Research/inVentiv Health to Present at Upcoming Jefferies 2017 London Healthcare Conference
RALEIGH, N.C., Nov. 03, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the Jefferies 2017 London Healthcare Conference....
Oct 19, 2017 05:02 pm ET
INC Research/inVentiv Health Schedules Third Quarter 2017 Earnings Call for Thursday, November 9, 2017
RALEIGH, N.C., Oct. 19, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully-integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract Commercial Organization), will release its third quarter 2017 financial results on Thursday, November 9, 2017, prior to its earnings call at 8:00 a.m. EST....
Jul 31, 2017 02:03 pm ET
Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against INC Research Holdings, Inc.
NEW YORK, July 31, 2017 /PRNewswire/ -- Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the District of Delaware, case No. 1:17-cv-00927, on behalf of shareholders of INC Research Holdings, Inc. ("INC" or the "Company") (NASDAQ: INCR) who have been harmed by INC's and its board of directors' (the "Board") alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") in connection with the proposed merger of the Company with inVentiv Health, Inc. ("inVentiv").
Jul 13, 2017 06:30 pm ET
Stull, Stull & Brody Announces Class Action Suit on Behalf of Shareholders of INC Research Holdings Inc. (NASDAQ: INCR)
NEW YORK, July 13, 2017 (GLOBE NEWSWIRE) -- Stull, Stull & Brody ("SS&B") announces that a class action lawsuit was commenced in the United States District Court for the District of Delaware on behalf of shareholders of INC Research Holdings Inc. (“INC” or the “Company”) (NASDAQ:INCR), alleging violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 in connection with the proposed merger between INC and inVentiv Health, Inc. (“inVentiv”)....
Jul 10, 2017 05:05 pm ET
INC Research Schedules Second Quarter 2017 Earnings Call for Thursday, July 27, 2017
RALEIGH, N.C., July 10, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, will release its second quarter 2017 financial results on Thursday, July 27, 2017, prior to its quarterly earnings call at 8:00 a.m. EDT....
Jun 28, 2017 08:10 pm ET
INC Research Grows Presence in Japan with Office Expansion and Relocation
RALEIGH, N.C., June 28, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization (CRO), today announced the expansion and relocation of its Tokyo, Japan office in support of the Company’s long-term growth strategy both in Japan and across the Asia/Pacific region....
Jun 14, 2017 04:51 pm ET
INC Research to Lead the Conversation on ICH E6 R2 Preparedness at DIA 2017 Annual Meeting
RALEIGH, N.C., June 14, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, today announced an extensive presence at the DIA 2017 53rd Annual Meeting being held June 18-22 in Chicago, Illinois. INC Research thought leaders will be participating in educational sessions covering new regulations for medical devices, accelerating research and development for rare diseases, innovative approaches to enrolling hard-to-find subjects, improving CRO and sponsor relations, and more. In addition, INC executives will be at B...
May 31, 2017 04:31 pm ET
INC Research to Present at Upcoming Jefferies Global Healthcare Conference
RALEIGH, N.C., May 31, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the 2017 Jefferies Global Healthcare Conference in New York, NY.  Mr. Macdonald’s presentation is scheduled for Wednesday, June 7, 2017, at 11 a.m. EDT....
May 04, 2017 03:46 pm ET
INC Research recognized by CSO Magazine for Second Consecutive Year for Innovative Employee Cyber Security Training Program
RALEIGH, N.C., May 04, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced it has been named to the 2017 CSO50 by IDG’s CSO magazine.  The annual CSO50 Awards recognize organizations (and the people within them) for security projects or initiatives that demonstrate outstanding business value and thought leadership. INC was recognized for an innovative and efficient cyber security training program used Companywide to ensure employees worldwide have the knowledge and tools necessary to protect sensi...
Apr 20, 2017 05:25 pm ET
INC Research Schedules First Quarter 2017 Earnings Call for Wednesday, May 10, 2017
RALEIGH, N.C., April 20, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, will release its first quarter 2017 financial results on Wednesday, May 10, 2017, prior to its quarterly earnings call at 8:00 a.m. EDT....
Mar 30, 2017 04:59 pm ET
Mar 30, 2017 12:51 pm ET
INC Research Strengthens Real World & Late Phase and Global Consulting Capabilities with Key Leadership Appointments
Additional senior-level expertise enhances global CRO’s strategic services offering, helping large pharma to meet their commercial objectives while strongly positioning the Company to capitalize on this growing market opportunity...
Mar 29, 2017 07:21 pm ET
Gartner Set to Join S&P 500; Dun & Bradstreet, Wintrust Financial and INC Research to Join S&P MidCap 400; Heska to Join S&P SmallCap 600
NEW YORK, March 29, 2017 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:
Mar 28, 2017 02:00 pm ET
INC Research Accelerates Clinical Trial Start-up with goBalto Activate
SAN FRANCISCO, March 28, 2017 /PRNewswire/ -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today results from its ongoing partnership with INC Research (NASDAQ: INCR), a leading global CRO and pioneer in the implementation of goBalto's end-to-end study startup platform to accelerate delivery of Phase I to IV clinical trials for global biopharmaceutical customers. INC Research continues to optimize its clinical study startup process on a worldwide basis, leveraging goBalto's technology to start more than 220 studies in more than 68 countries t
Feb 22, 2017 05:54 pm ET
INC Research Expands Functional Service Provider Services Through New Investigator Payment Offering
RALEIGH, N.C., Feb. 22, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, today announced expansion of its Functional Service Provider (FSP) service offering to include investigator payment processing, leveraging  the Company’s extensive expertise and delivery of  customized solutions in this area as well as insights gained from its industry-recognized site relationships. The addition of investigator payment processing to the Company’s FSP offering builds on its nearly 20 years of experience in meeting the nee...
Feb 08, 2017 05:11 pm ET
INC Research Further Strengthens Board of Directors Through Appointment of Pharmaceutical Executive Eric P. Pâques
RALEIGH, N.C., Feb. 08, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, today announced the appointment of Eric Paul Pâques, previously the Chief Executive Officer for GRÜNENTHAL GROUP, to the Company’s Board of Directors.  Mr. Pâques joins the INC Research Board as an independent director and will be a Class I director serving a term ending at the Company’s 2018 Annual Meeting....
Nov 14, 2016 04:15 pm ET
INC Research to Present at Upcoming Nasdaq Investor Conference
RALEIGH, N.C., Nov. 14, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that Chief Executive  Officer Alistair Macdonald is scheduled to present at the Nasdaq 35th Investor Program in London, UK. Mr. Macdonald’s  presentation is scheduled for Tuesday, Nov. 29, 2016, at 10:30 a.m. GMT....
Oct 31, 2016 06:05 am ET
INC Research Announces Updates to Board of Directors
RALEIGH, N.C., Oct. 31, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced the appointment of Kenneth F. Meyers, Senior Vice President and Chief Human Resources Officer at Hill-Rom to the Company’s Board of Directors and the Compensation Committee of the Board and Matthew E. Monaghan, President and Chief Executive Officer at Invacare Corporation, to the Company’s Board of Directors and the Nominating and Corporate Governance Committee of the Board.  Both Mr. Meyers and Mr. Monaghan join the INC R...
Oct 31, 2016 06:00 am ET
Oct 24, 2016 08:30 am ET
INC Research Receives 2016 Frost & Sullivan Asia Pacific Contract Research Outsourcing Services Customer Value Leadership Award
RALEIGH, N.C., Oct. 24, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced it has been awarded the 2016 Frost & Sullivan Asia Pacific Contract Research Outsourcing Services Customer Value Leadership Award. The Company was recognized for successfully expanding its customer base in the Asia/Pacific region and driving significant repeat business while demonstrating a consistent focus on helping to speed/accelerate the delivery of ground-breaking products to market. Other successes that contrib...
Oct 19, 2016 04:50 pm ET
INC Research to Present at Upcoming Credit Suisse Healthcare Conference
RALEIGH, N.C., Oct. 19, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that Chief Financial Officer Greg Rush is scheduled to present at the  25th Annual Credit Suisse Healthcare Conference in Scottsdale, Arizona. Mr. Rush’s  presentation is scheduled for Tuesday, Nov. 8, 2016, at 10:00 a.m. Mountain Time....
Oct 18, 2016 11:01 am ET
INC Research Marks 20-Year Milestone in Managing Antiretroviral Pregnancy Registry
RALEIGH, N.C., Oct. 18, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, is commemorating its milestone of managing the Antiretroviral Pregnancy Registry (APR), the largest and longest-running pregnancy exposure registry of its kind that has enrolled more than 20,000 prospective pregnancies from 70 countries over the last quarter century. As a voluntary, international study designed to collect data on pregnancy outcomes, the APR is the primary source for evaluating the safety of antiretroviral (ARV) drugs us...
Oct 12, 2016 05:15 pm ET
INC Research Schedules Third Quarter 2016 Earnings Call for Monday, October 31, 2016
RALEIGH, N.C., Oct. 12, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, will release its third quarter 2016 financial results on Monday, Oct. 31, 2016, prior to its quarterly earnings call at 8:00 a.m. EDT....
Oct 12, 2016 11:28 am ET
INC Research Demonstrates Ongoing Commitment to Clinical Research Sites at SCRS 2016 Global Site Solutions Summit
RALEIGH, N.C., Oct. 12, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced its extensive participation in the Society for Clinical Research Sites' (SCRS) 11th Annual Global Site Solutions Summit Oct. 13-16 in Boca Raton, Fla. INC Research thought leaders will participate in seven sessions to discuss issues that impact the way sites conduct research and recruit patients, while offering strategies to improve collaboration between CROs and sites to more effectively benefit patients....
Oct 03, 2016 08:00 am ET
INC Research Announces Executive Leadership Promotions
RALEIGH, N.C., Oct. 03, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced the promotions of Michael Gibertini, PhD, and Tara Fitzgerald to key executive leadership roles within the Company. Dr. Gibertini, who currently serves as INC Research’s President, Clinical Development, has been promoted to Chief Operating Officer (COO) succeeding Alistair Macdonald while Tara Fitzgerald, Executive Vice President, Biometrics, has been appointed President, Clinical Development Services.  The appointment...
Sep 29, 2016 11:31 am ET
INC Research and CISCRP Announce Winner of “Inspiring Hope” Ideathon
RALEIGH, N.C., Sept. 29, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, together with the Center for Information and Study on Clinical Research Participation (CISCRP), a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process, today announced Team “C2: The Clinical Study Change Agent Collective” was chosen as the winner of the 2016 “Inspiring Hope” Ideathon.  Team C2 was selected because judges felt the team’s idea to create a corporate social resp...
Sep 14, 2016 07:31 am ET
INC Research and CISCRP Announce Finalists for “Inspiring Hope” Ideathon
RALEIGH, N.C., Sept. 14, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, together with the Center for Information and Study on Clinical Research Participation (CISCRP), a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process, today announced the finalists for the “Inspiring Hope” Ideathon event. In a competition that inspired nearly 70 entries, 14 ideas submitted by teams from around the world have been shortlisted for their potential to help addr...
Aug 25, 2016 05:46 pm ET
INC Research to Present at Upcoming September Conferences
RALEIGH, N.C., Aug. 25, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that it will participate in two upcoming investor conferences. Presenting at the conferences will be Greg Rush, Chief Financial Officer....
Aug 16, 2016 04:26 pm ET
INC Research Announces Secondary Offering and Repurchase of Common Stock
RALEIGH, N.C., Aug. 16, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR) (the “Company”), a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, namely affiliates of Avista Capital Partners, L.P. and affiliates of Ontario Teachers’ Pension Plan, intend to offer for sale in an underwritten secondary offering 4,500,000 shares of the Company’s common stock (the “Offering”) pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission (“SEC”). INC Research will ...
Aug 02, 2016 09:31 am ET
INC Research's Jean Chitwood Named to Annual PharmaVOICE 100
RALEIGH, N.C., Aug. 02, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced Jean Chitwood, Executive Vice President, Corporate Strategy and Development, has been named to this year’s PharmaVOICE 100 list celebrating influential and inspirational leaders throughout the life sciences industry. An executive with INC Research for nearly 10 years, Ms. Chitwood was recognized for her strategic vision, passion and focus on helping her peers advance the Company and build INC Research into a successful g...
Aug 01, 2016 05:25 pm ET
INC Research Announces 2016 Analyst and Investor Day
RALEIGH, N.C., Aug. 01, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that it will host an Analyst and Investor Day Conference at the NASDAQ Market Site in New York City on Tuesday, Aug. 16, 2016 with management and speaker presentations beginning at 8:00 a.m Eastern Time....
Aug 01, 2016 06:43 am ET
INC Research Announces Secondary Offering
RALEIGH, N.C., Aug. 01, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR) (the “Company”), a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, namely affiliates of Avista Capital Partners, L.P. and affiliates of Ontario Teachers’ Pension Plan, intend to offer for sale in an underwritten secondary offering 5,000,000 shares of the Company’s Class A common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission (“SEC”). INC Research will not recei...
Jul 28, 2016 06:40 am ET
INC Research Announces Transition of CEO Role from Jamie Macdonald to COO Alistair Macdonald Effective Oct. 1, 2016
RALEIGH, N.C., July 28, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced that Chief Executive Officer Jamie Macdonald will transition his role as CEO of the Company effective Oct. 1, 2016, to INC Research’s current President and COO Alistair Macdonald. Mr. Alistair Macdonald, who has served as INC’s President and COO since January 2013 and held various other leadership roles at the Company since 2002, will become a member of the Company’s Board of Directors on Oct. 1.  Mr. Jamie Macdonald wil...
Jul 28, 2016 06:21 am ET
Jul 27, 2016 01:42 pm ET
INC Research and CISCRP Announce Judging Panel, Sponsors  and Mentors for “Inspiring Hope” Ideathon Event
RALEIGH, N.C., July 27, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, together with the Center for Information and Study on Clinical Research Participation (CISCRP), a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process, today announced the judging panel, sponsors and mentors for the upcoming “Inspiring Hope” Ideathon event, an innovative competition designed to develop effective new ways to increase the awareness of clinical trial participati...
Jul 27, 2016 09:52 am ET
INC Research Extends Catalyst Program with Launch of Vaccine Catalyst Site Network
RALEIGH, N.C., July 27, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced the launch of the Company’s Vaccine Catalyst Site network as part of its Catalyst program introduced earlier this year to strengthen collaborations with clinical research sites worldwide, ultimately enhancing patient focus and optimizing study delivery to drive improved predictability and increased efficiency for customers.  INC selected 40 high-performing clinical research sites to participate in the initial launch ...
Jul 26, 2016 10:15 am ET
INC Research Attains Bronze Standard under the IAOCR Clinical Operations Workforce Quality Accreditation Program
RALEIGH, N.C., July 26, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, and IAOCR, an internationally recognized accrediting organization for the clinical research industry, today announced INC Research has achieved the “Bronze Standard” within the IAOCR Clinical Operations Workforce Quality Accreditation program.  INC is the first CRO to achieve accreditation under the new program, which is designed to serve as an international benchmark on clinical operations excellence....
Jul 19, 2016 04:34 pm ET
INC Research and CISCRP Announce Keynote Speaker for “Inspiring Hope” Ideathon Event to Help Raise Awareness of Clinical Trials
RALEIGH, N.C., July 19, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, together with the Center for Information and Study on Clinical Research Participation (CISCRP), a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process, today announced cancer “thriver” (reflecting her triumph over cancer and striving to live the best life possible following diagnosis) and clinical research advocate Jameisha Brown will be the keynote speaker at the upcoming “Ins...
Jul 15, 2016 04:06 pm ET
INC Research Schedules Second Quarter 2016 Earnings Call for Thursday, July 28th, 2016
RALEIGH, N.C., July 15, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, will release its second quarter 2016 financial results on Thursday, July 28, 2016, prior to its quarterly earnings call at 8:00 a.m. EDT....
Jun 22, 2016 09:04 am ET
INC Research to Connect with the Clinical Research Community at DIA 2016 Annual Meeting to Emphasize Collaboration in Bringing New Therapies to Market
RALEIGH, N.C., June 22, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, will demonstrate its continued commitment to making connections across the entire clinical development community with an extensive presence at the DIA 2016 52nd Annual Meeting June 26-29 in Philadelphia, Pennsylvania. INC Research thought leaders will be participating in educational sessions covering strategic partnerships, evolving methods in pain trials, risk-based monitoring and more. In addition, INC executives will be at Booth #2101...
May 31, 2016 05:51 pm ET
INC Research Announces the Retirement of James T. Ogle, Chairman of the Board of Directors
RALEIGH, N.C., May 31, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced the retirement of James T. Ogle as Chairman of the Board of Directors and as a Director of the Company, effective today. Mr. Ogle has been a member of the INC Research Board of Directors since 2003 and served as the Company’s CEO from 2003 to 2013 leading the Company through unprecedented growth....
May 25, 2016 04:57 pm ET
INC Research to Present at Upcoming Investor Conferences
RALEIGH, N.C., May 25, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that it will participate in two upcoming investor conferences. Presenting at the conferences will be Jamie Macdonald, Chief Executive Officer....
May 25, 2016 08:00 am ET
INC Research Expands Presence in Japan with New Osaka Office
RALEIGH, N.C., May 25, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization (CRO), today announced the relocation and expansion of its Osaka, Japan office in support of the Company’s long-term growth strategy both in Japan and across the Asia/Pacific region. Since the beginning of 2015 INC Research’s Japanese operations have more than tripled their employee headcount and expect continued strong growth. The new Osaka office further expands the Company's presence in the Asia/Pacific region to provide its global dru...
May 20, 2016 09:00 am ET
INC Research and CISCRP Launch “Inspiring Hope” Ideathon to Boost Community Involvement in Raising Awareness of Clinical Research
RALEIGH, N.C., May 20, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, together with the Center for Information and Study on Clinical Research Participation (CISCRP), a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process, have announced an innovative new initiative designed to promote greater awareness of the importance of clinical trial participation in advancing public health. The “Inspiring Hope” Ideathon, which kicks off June 1 and culminate...
May 02, 2016 04:35 pm ET
INC Research Announces Secondary Offering
RALEIGH, N.C., May 02, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR) (the “Company”), a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, namely affiliates of Avista Capital Partners, L.P. and affiliates of Ontario Teachers’ Pension Plan, intend to offer for sale in an underwritten secondary offering 8,000,000 shares of the Company’s Class A common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission (“SEC”). INC Research will not receiv...
May 02, 2016 06:00 am ET